[HTML][HTML] Novel nanotechnology-based approaches for targeting HIV reservoirs
Highly active anti-retroviral therapy (HAART) is prescribed for HIV infection and, to a certain
extent, limits the infection's spread. However, it cannot completely eradicate the latent virus …
extent, limits the infection's spread. However, it cannot completely eradicate the latent virus …
[HTML][HTML] Stem cell transplantation in strategies for curing HIV/AIDS
G Hütter - AIDS research and therapy, 2016 - Springer
HIV-1 can persist in a latent form in resting memory CD4+ cells and macrophages carrying
an integrated copy of the HIV genome. Because of the presence of these stable reservoir …
an integrated copy of the HIV genome. Because of the presence of these stable reservoir …
Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept
The inadequate bioavailability and toxicity potential of antiretroviral therapy limit their
effectiveness in the complete eradication of HIV from viral reservoirs. The penetration of …
effectiveness in the complete eradication of HIV from viral reservoirs. The penetration of …
Recent advances in HIV-associated cardiovascular diseases in Africa
The last decade has witnessed major advances in our understanding of the epidemiology
and pathophysiology of HIV-related cardiovascular disease in sub-Saharan Africa. In this …
and pathophysiology of HIV-related cardiovascular disease in sub-Saharan Africa. In this …
Heart health in the age of highly active antiretroviral therapy: A review of HIV cardiomyopathy
MN Belkin, N Uriel - Current Opinion in Cardiology, 2018 - journals.lww.com
The widespread use of HAART has led to prolonged survival in HIV patients to the point that
cardiac disease has become the most common cause of death. Patients should be treated …
cardiac disease has become the most common cause of death. Patients should be treated …
Cardiovascular disease in patients with chronic human immunodeficiency virus infection
Abstract In 2012, the United Nations estimated that globally, 34 million people were living
with human immunodeficiency virus (HIV) infection at the end of 2011. About 6.5% of AIDS …
with human immunodeficiency virus (HIV) infection at the end of 2011. About 6.5% of AIDS …
Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy
E Auerbach, DM Aboulafia - Seminars in thrombosis and …, 2012 - thieme-connect.com
With the advent of highly active antiretroviral therapy (HAART), dramatic improvements have
been made in the quality and length of life in people living with HIV/AIDS (PLWA) …
been made in the quality and length of life in people living with HIV/AIDS (PLWA) …
Acute myocarditis in children
KE Simpson, CE Canter - Expert review of cardiovascular therapy, 2011 - Taylor & Francis
Myocarditis is an uncommon but significant disease in children. Diagnosis requires a high
index of suspicion and understanding of the clinical presentation of this disease. The …
index of suspicion and understanding of the clinical presentation of this disease. The …
Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients
A Karavidas, G Xylomenos, V Matzaraki… - Clinical Research in …, 2015 - Springer
Background Patients infected by the human immunodeficiency virus (HIV) and receiving
highly active antiretroviral therapy have a higher incidence of cardiovascular disease than …
highly active antiretroviral therapy have a higher incidence of cardiovascular disease than …
Anti-HIV-1 drug toxicity and management strategies
B Sharma - Neurobehavioral HIV Medicine, 2011 - Taylor & Francis
Antihuman immunodeficiency virus type 1 (anti-HIV-1) medications have helped millions of
HIV-1-infected people lead longer and healthier lives. The goal of HIV-1 treatment is to …
HIV-1-infected people lead longer and healthier lives. The goal of HIV-1 treatment is to …